![CDC0032 Intermediate Imidazo[1,2-d][1,4]benzoxazepine, 9-bromo-5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]-](https://img.nicebiochem.com/bw-crm-product%2Fyuanye.png?x-oss-process=image/resize,m_fixed,h_800,w_800)
CDC0032 Intermediate Imidazo[1,2-d][1,4]benzoxazepine, 9-bromo-5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]-
-
1H-Pyrazole-1-acetic acid, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9- 1H-Pyrazole-1-acetic acid, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-
S82713-100mg | 100mg
-
1H-Pyrazole-1-acetic acid, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9- 1H-Pyrazole-1-acetic acid, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-, ethyl ester
S82715-100mg | 100mg
-
Taselisib (GDC-0032; RG-7604) 4-[5,6-Dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9
S80249-2mg | 2mg
-
Taselisib (GDC-0032; RG-7604) 4-[5,6-Dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9
S80249-5mg | 5mg
-
Taselisib (GDC-0032; RG-7604) 4-[5,6-Dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9
S80249-1mg | 1mg
-
Taselisib (GDC-0032; RG-7604) 4-[5,6-Dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9
S80249-25mg | 25mg
-
Taselisib (GDC-0032; RG-7604) 4-[5,6-Dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9
S80249-10mg | 10mg
分子式：C17H18BrN5O
分子量：388.2617
储存条件：-20℃
外观：
用途：本品仅供科研，不得用于其它用途。
您正在浏览的产品：CDC0032 Intermediate
本公司销售的所有产品仅供实验科研使用，不用于人体及临床诊断。